(Q34054140)

30 July 2017

1 reference

title

Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy (English)

1 reference

30 July 2017

0 references

cervix uterine cancer

1 reference

Smith RS

1

1 reference

30 July 2017

Kapp DS

series ordinal

2

1 reference

30 July 2017

Chen Q

series ordinal

3

1 reference

30 July 2017

Teng NN

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

International Journal of Radiation Oncology Biology Physics

30 July 2017

1 reference

30 July 2017

48

1 reference

30 July 2017

767-778

1 reference

30 July 2017

3

1 reference

30 July 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine papillary serous carcinoma. A clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Papillary serous adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), age, FIGO grade and nuclear grade

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Abdominal radiotherapy for cancer of the uterine cervix and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Surgical stage IV endometrial carcinoma: a study of 47 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Endometrial adenocarcinoma in Norway. A study of a total population

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

The National Cancer Data Base report on endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Surgical staging of gynecologic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

The management of stage III carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Stage III adenocarcinoma of the endometrium: two prognostic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Stage III endometrial carcinoma. A review of 90 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Stage I serous papillary carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

Whole abdominal irradiation for tumors of the uterine corpus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900724-0

7 January 2021

10.1016/S0360-3016(00)00724-0

Identifiers

DOI

1 reference

30 July 2017

1 reference